Literature DB >> 24548784

Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.

Daniela Valenti1, Lidia de Bari1, Bianca De Filippis2, Alexandra Henrion-Caude3, Rosa Anna Vacca4.   

Abstract

Clinical manifestations typical of mitochondrial diseases are often present in various genetic syndromes associated with intellectual disability, a condition leading to deficit in cognitive functions and adaptive behaviors. Until now, the causative mechanism leading to intellectual disability is unknown and the progression of the condition is poorly understood. We first report latest advances on genetic and environmental regulation of mitochondrial function and its role in brain development. Starting from the structure, function and regulation of the oxidative phosphorylation apparatus, we review how mitochondrial biogenesis and dynamics play a central role in neurogenesis and neuroplasticity. We then discuss how dysfunctional mitochondria and alterations in reactive oxygen species homeostasis are potentially involved in the pathogenesis of various neurodevelopmental syndromes with a special focus on Down, Rett, Fragile X syndromes and autism spectrum disorders. Finally, we review and suggest novel therapeutic approaches aimed at improving intellectual disability by activating mitochondrial function and reducing oxidative stress to amiliorate the quality of life in the subjects affected.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autism; Down syndrome; Drug development; Epigallocatechine-3-gallate; Fragile X; Intellectual disability; Mitochondria; Mitochondrial dysfunction; Neurogenesis; Neuroplasticity; Oxidative phosphorylation; Oxidative stress; Rett syndrome

Mesh:

Substances:

Year:  2014        PMID: 24548784     DOI: 10.1016/j.neubiorev.2014.01.012

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  50 in total

1.  Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease.

Authors:  Fabio Di Domenico; Gilda Pupo; Cesare Mancuso; Eugenio Barone; Francesca Paolini; Andrea Arena; Carla Blarzino; Frederick A Schmitt; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Differential Mitochondrial Requirements for Radially and Non-radially Migrating Cortical Neurons: Implications for Mitochondrial Disorders.

Authors:  Erika G Lin-Hendel; Meagan J McManus; Douglas C Wallace; Stewart A Anderson; Jeffrey A Golden
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423

3.  Toxicant-mediated redox control of proteostasis in neurodegeneration.

Authors:  Stefanos Aivazidis; Colin C Anderson; James R Roede
Journal:  Curr Opin Toxicol       Date:  2018-12-28

Review 4.  Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors:  Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-30

5.  Mitochondrial dysfunction underlies cognitive defects as a result of neural stem cell depletion and impaired neurogenesis.

Authors:  Mireille Khacho; Alysen Clark; Devon S Svoboda; Jason G MacLaurin; Diane C Lagace; David S Park; Ruth S Slack
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

6.  Chromosome 21-derived hsa-miR-155-5p regulates mitochondrial biogenesis by targeting Mitochondrial Transcription Factor A (TFAM).

Authors:  Adolfo Quiñones-Lombraña; Javier G Blanco
Journal:  Biochim Biophys Acta       Date:  2015-04-11

7.  Inefficient thermogenic mitochondrial respiration due to futile proton leak in a mouse model of fragile X syndrome.

Authors:  Keren K Griffiths; Aili Wang; Lifei Wang; Matthew Tracey; Giulio Kleiner; Catarina M Quinzii; Linlin Sun; Guang Yang; Jose F Perez-Zoghbi; Pawel Licznerski; Mu Yang; Elizabeth A Jonas; Richard J Levy
Journal:  FASEB J       Date:  2020-04-20       Impact factor: 5.191

8.  Novel interactive partners of neuroligin 3: new aspects for pathogenesis of autism.

Authors:  Chen Shen; Li-rong Huo; Xin-liang Zhao; Pei-rong Wang; Nanbert Zhong
Journal:  J Mol Neurosci       Date:  2014-12-03       Impact factor: 3.444

9.  A recurrent missense variant in SLC9A7 causes nonsyndromic X-linked intellectual disability with alteration of Golgi acidification and aberrant glycosylation.

Authors:  Wujood Khayat; Anna Hackett; Marie Shaw; Alina Ilie; Tracy Dudding-Byth; Vera M Kalscheuer; Louise Christie; Mark A Corbett; Jane Juusola; Kathryn L Friend; Brian M Kirmse; Jozef Gecz; Michael Field; John Orlowski
Journal:  Hum Mol Genet       Date:  2019-02-15       Impact factor: 6.150

10.  Dosage compensation can buffer copy-number variation in wild yeast.

Authors:  James Hose; Chris Mun Yong; Maria Sardi; Zhishi Wang; Michael A Newton; Audrey P Gasch
Journal:  Elife       Date:  2015-05-08       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.